Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500341 · ClinicalTrials.gov registry record
Oxygen Reserve Index (ORi) Validation of INVSENSOR00014
A clinical trial, sponsored by Masimo Corporation.
- Terminated
- Registry status
- 33
- Enrollment target
NCT03500341 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 33 participants.
The verdict
NCT03500341 was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above.) In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. The ORI device measurement is analyzed by comparing it to the PaO2 measurements from blood samples from a laboratory analyzer.
Interventions
- DEVICE INVSENSOR00014
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2018-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500341
The ClinicalTrials.gov registry entry for NCT03500341 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00014 is the first listed.
NCT03500341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500341 about?
NCT03500341 is a clinical study titled "Oxygen Reserve Index (ORi) Validation of INVSENSOR00014". The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2...
What is the current status of trial NCT03500341?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2018-03-21. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT03500341?
The interventions under investigation include: INVSENSOR00014 (DEVICE).
Who is sponsoring clinical trial NCT03500341?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.